MorphoSys AG (ETR:MOR) Receives Consensus Recommendation of "Buy" from Analysts
MorphoSys AG (ETR:MOR – Get Rating) has been given a consensus rating of “N/A” by the seven brokerages that are currently covering the company, Marketbeat Ratings reports. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is €55.14 ($59.94). MOR has been the topic […]
Source: etfdailynews.com
